TPB spent $12 million supporting its PMTA submissions, which totaled 81,000 pages in length.
In the end, all their science meant nothing because the FDA, years after announcing companies would be required to submit PMTAs, decided to set a new product standard. #FDALawsuits
"FDA failed to consider the consequences of an across-the-board prohibition on flavored ENDS for millions of adult former smokers who will suddenly lose access to the products they have depended on to quit."
"A mass exodus...also risks pushing countless
smokers back to [cigs]."
A sample of what TPB spent $12 million on, only to have some junior level bureaucrat do a bare minimum review so nearly every application they filed could be denied.
How long did it take Matt Holman from the FDA CTP Office of 'Science' to concur with recommendations to deny TPB's PMTAs?
An hour.
And all this after FDA wouldn't even meet with TBP pre-COVID to discuss what studies would be required.
As TPB points out, the FDA acknowledged that it was not until they began reviewing PMTAs that they decided to change their requirements for authorization.
"FDA cannot now penalize TPB for following FDA's instructions."
How intensive was the FDA's review process?
Products with identical formulations but different names received different outcomes.
John Marshall (right), a senior director for America's largest cigarette company Altria, testifying in favor of a bill (HB 2211) that would decimate small businesses and increase his company's cigarette sales.
Law enforcement "expert" here for more anti-China propaganda. #MOLeg
Altria's "expert" notes that China has banned the sale of flavored vaping products.
He leaves out that China owns the world's largest cigarette company. Competition is bad for revenue.
In her speech, FDA CTP's Kathleen Crosby (Director of the Office of Health Comm. and Edu.) approvingly used the third quote to say youth risk perceptions have "changed in the way that we would hope that they would." #SRNT2022
In the very same speech, Crosby highlights misperceptions held by adult smokers.
"It wasn't understood that vaping is a less harmful way to get nicotine because the product isn't burned."
Maybe the education campaign promised for 5+ years could help, @FDATobacco? #SRNT2022
@FDATobacco Nancy Rigotti: Will FDA will communicate accurate information about nicotine to adult smokers?
Crosby: "We're really well aware of those issues and trying to create a delicate balance between youth prevention and adult cessation while still being true to the science." #SRNT2022
Dr. Michael Cummings, who is a longtime opponent of smoking and friendly to the harm reduction debate, up first with a review of the tobacco wars and today's conflicts. #SRNT2022
About three hours ago, @Jamie_Ducharme's BIG VAPE arrived in my mailbox. Excluding the notes section, it's just 260 pages, so it made for a quicker read than the substantially thicker DEVIL'S PLAYBOOK (by @lauren_etter).
It exceeded my expectations.
SHORT THREAD 👇
Ducharme and Etter were both concurrently writing books about the same overarching topic, but took different approaches.
BIG VAPE is very much the story of Juul; not the stories of Juul, Altria, and angry rich white parents like Etter's book. They complement each other well.
Whereas Etter often comes off as overly sympathetic to the prohibitionists, Ducharme generally finds the right mix. Antis, as well as harm reduction advocates like David Abrams, Ray Niaura, Cheryl Healton, @Clive_Bates, @mbsiegel, @JustJulie_MO, @Hello_Alex and myself are quoted.
I am very proud to announce that @bearmanormedia has signed on to release my first nonfiction book, which is tentatively titled MERCHANTS OF Bs.
The book is the result of hundreds of interviews and a lot of $$$ spent on legal documents from various court archives.
/1
This project started 10+ years ago. I assumed it would take two years to finish, but my decision to dedicate the majority of my life to tobacco harm reduction caused it to be an on-again, off-again project.
When COVID hit and travel stopped, I decided it was do or die time.
/2
So, what is the book about? In short, it aims to tell the story of several producers, distributors, and international sales agents of lower-budget genre films during and after the 1980s home video boom.
"Explain that in English," you might be saying.
/3